Estrogenicity of lignans in immature rats as measured by uterine weight
Treatment group . | n . | Relative uterine weight (mg/100 g bw) . |
---|---|---|
Control | 9 | 46 ± 5a |
Control + 10% ethanol | 5 | 48 ± 8a |
Diethylstilbestrol 2 μg/kg bw | 8 | 164 ± 20b |
Finrozole 10 mg/kg bw | 6 | 31 ± 3c |
ENL 50 mg/kg bw | 6 | 47 ± 5a |
MR 50 mg/kg bw | 4 | 55 ± 9a |
SECO 50 mg/kg bw | 6 | 49 ± 6a |
HMR 50 mg/kg bw | 6 | 49 ± 7a |
Treatment group . | n . | Relative uterine weight (mg/100 g bw) . |
---|---|---|
Control | 9 | 46 ± 5a |
Control + 10% ethanol | 5 | 48 ± 8a |
Diethylstilbestrol 2 μg/kg bw | 8 | 164 ± 20b |
Finrozole 10 mg/kg bw | 6 | 31 ± 3c |
ENL 50 mg/kg bw | 6 | 47 ± 5a |
MR 50 mg/kg bw | 4 | 55 ± 9a |
SECO 50 mg/kg bw | 6 | 49 ± 6a |
HMR 50 mg/kg bw | 6 | 49 ± 7a |
Relative weights with the different letters a, b, and c indicate statistically significant differences. (P < 0.05) between the treatment groups tested by Kruskal-Wallis (median) test followed by Mann-Whitney U test.